Howard Hochster, MD, Explains Colorectal Cancer Screening Guidelines

Article

Howard S. Hochster, an oncologist at Yale Cancer Center who specializes in gastrointestinal cancers, explains when and why individuals should consider colorectal cancer screening.

Howard S. Hochster, an oncologist at Yale Cancer Center who specializes in gastrointestinal cancers, explains that screening for colon cancer is recommended to begin at age 50 due to the increase in cancer incidence at that age. However, adults under 50, including those who may be considered at high risk due to factors related to genetics or lifestyle, can also be diagnosed with the disease. "It's still kind of rare to have people in their 40s develop colorectal cancer," he says, but it does happen.

Current guidelines recommend individuals age 50 and older receive colonoscopies every 10 years if they do not have a history of polyps. If a screening exam has identified polyps, more frequent colonoscopies may be recommended.

For people who are at higher risk, they should be screened earlier, around age 40, he says. A common high-risk factor includes having a first-degree relative with a history of colorectal cancer, especially if that family member was diagnosed before age 55.

For more information on colorectal cancer screening and prevention, visit https://www.curetoday.com/tumor/colorectal

Related Videos
Jessica McDade, B.S.N., RN, OCN, in an interview with CURE
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Dr. Nguyen, from Stanford Health, in an interview with CURE
Dr. Barzi in an interview with CURE